Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Brian Wissel

Sports Medicine Lawrenceburg, IN Medical Doctor

NPI 1386082915 CMS profile 108175

605 Wilson Creek Rd, Lawrenceburg, IN 47025

Open in the dashboard

General payments

$34,084

177 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Brian Wissel of Lawrenceburg, IN is reported in the CMS Open Payments database as having received $34,084 across 177 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 79th percentile of Sports Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $451 8
2024 General $3,090 40
2023 General $2,222 23
2022 General $5,441 22
2021 General $7,639 33
2020 General $2,790 10
2019 General $12,451 41

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Brian Wissel
  • Sports Medicine median
  • Middle half of Sports Medicine
  • National median

In program year 2025, general payments to Brian Wissel were reported at $451. Among 2,404 Sports Medicine profiles paid that year, the median was $664 and the middle half received between $172 and $3,055.

Show as a table
Year Brian Wissel Sports Medicine median Middle half National median
2019 $12,451 $1,176 $199–$4,249 $163
2020 $2,790 $708 $96–$2,890 $114
2021 $7,639 $1,213 $152–$3,994 $132
2022 $5,441 $1,230 $159–$3,998 $149
2023 $2,222 $584 $146–$2,836 $160
2024 $3,090 $628 $163–$3,168 $164
2025 $451 $664 $172–$3,055 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Arthrex, Inc. $11,098 69 payments
  2. Smith+Nephew, Inc. $8,626 19 payments
  3. Legacy Ortho LLC $7,663 34 payments
  4. Alon Medical Technology $2,980 4 payments
  5. Medical Device Business Services, Inc. $957 8 payments
  6. Stryker Corporation $808 12 payments
  7. DePuy Synthes Sales Inc. $638 13 payments
  8. Miach Orthopaedics, Inc. $398 2 payments
  9. Zimmer Biomet Holdings, Inc. $242 3 payments
  10. Medacta USA, Inc. $199 4 payments
  11. Other $476 9 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Education $20,371 14 payments
  2. Travel and Lodging $6,868 31 payments
  3. Food and Beverage $6,846 132 payments
Products named General payments · program years 2019–2025
  1. GRYPHON $951 8 payments
  2. MILAGRO $835 7 payments
  3. TRIGEN INTERTAN $632 6 payments
  4. MAKO Knees, Hips $311 4 payments
  5. VA-LCP PLATES & SCREWS $227 5 payments
  6. Persona $216 2 payments
  7. BLUEPRINT PATIENT SPECIFIC INSTRUMENTATION $192 3 payments
  8. DYNACORD $192 2 payments
  9. TFN-Advance $169 4 payments
  10. MAKO Knees, Hips $150 1 payment
  11. Other $2,601 48 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 10 drugs

Part D claims

322

Median for Orthopedic Surgery: 203

Drug cost

$1,682

Median for Orthopedic Surgery: $1,433

Branded share of claims

29.8%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 52 $345
Cyclobenzaprine Hcl Generic 34 $338
Diclofenac Sodium Generic 13 $234
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 23 $155
Ondansetron Odt Ondansetron Brand 21 $149
Meloxicam Generic 79 $141
Ibuprofen Generic 26 $132
Methylprednisolone Generic 22 $93
Methocarbamol Generic 28 $54
Tramadol Hcl Generic 24 $42

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 97 billing codes

Paid by Medicare

$164,447

Of which drugs: $5,392

Medicare patients

399

Average age 74

Services billed

6,143

248 women, 151 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 73%
Depression 35%
Diabetes 33%
Ischemic heart disease 29%
Chronic kidney disease 25%
COPD 22%
Heart failure 18%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 155 1,196 $810

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

177 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Sports Medicine in Indiana

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record